Novartis AG NVS

145.46 2.75 1.93% as of 25 Sep
Market cap
$264.3B
P/E
21.8×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
40.05 103.59 14.16 18.53 26.60 8.16 28.91 14.05 16.47 19.15
P/S ratio
0.00 0.00 3.87 4.46 4.31 3.71 4.63 4.50 3.80 4.72
P/FCF ratio
0.00 0.00 14.21 16.44 18.64 14.99 16.32 15.10 14.06 17.34
P/Operating CF
(21.61) (26.12) 47.35 61.28 53.69 50.51 48.92 82.36 46.83 118.08
P/B ratio
0.00 0.00 2.27 3.91 3.79 2.89 3.38 4.49 4.45 5.74
EV/Sales
(1.25) (1.40) 4.22 4.78 4.80 3.73 4.79 4.71 4.11 5.10
EV/EBITDA
0.00 0.00 19.02 18.77 18.01 16.86 13.97 16.53 12.11 12.62
EV/FCF
(6.51) (6.62) 15.50 17.64 20.77 15.06 16.91 15.83 15.21 18.76
Current Ratio
1.12 1.21 1.20 1.04 0.90 1.51 1.29 1.16 1.04 1.12
Net Debt/EBITDA
1.12 1.30 1.19 1.07 1.50 0.07 0.49 0.56 0.78 0.96
Debt/Equity
0.32 0.38 0.41 0.49 0.64 0.43 0.44 0.53 0.67 0.72
ROE
8.83% 10.33% 16.49% 17.48% 14.39% 38.59% 10.93% 27.97% 26.28% 30.84%
ROA
5.13% 5.85% 9.05% 8.89% 6.56% 18.51% 5.58% 13.66% 11.81% 13.12%
ROIC
5.68% 5.78% 5.54% 7.94% 7.82% 10.64% 7.45% 10.72% 15.08% 16.10%
Return on Tangible Assets
36.55% 36.22% 58.24% 88.15% 90.93% 88.79% 36.57% 109.15% 114.05% 100.14%
Average Days of Receivables
61.71 64.08 71.06 64.15 61.86 57.18 69.99 58.93 53.32 58.88
Earnings Yield
2.50% 0.97% 7.06% 5.40% 3.76% 12.26% 3.46% 7.12% 6.07% 5.22%
Free Cash Flow Yield
(12.19%) (11.87%) 7.04% 6.08% 5.36% 6.67% 6.13% 6.62% 7.11% 5.77%
Free Cash Flow per Share
3.98 4.50 5.41 5.76 5.07 5.84 5.65 6.69 6.92 7.95
Book value per Share
31.49 31.64 33.93 24.25 24.89 30.24 27.25 22.51 21.87 24.01
Free Cash Flow
9,455.00 10,566.00 12,549.00 13,198.00 11,533.00 13,088.00 12,325.00 13,897.00 13,971.00 15,421.00
EV/EBIT
0.00 0.00 22.80 25.63 23.59 16.86 26.22 22.52 14.61 16.40
Other line items

Show all line items

Columns are period end dates